Kaneka Probiotics is proud to announce that its KABP® Menopause blend has won the 2025 NutraIngredients-USA Award for Microbiome Modulation. As a leading probiotic manufacturer, Kaneka’s commitment to advancing science-driven, next-generation probiotics has earned this recognition, reinforcing the company’s role in shaping the future of women’s health.
The award-winning KABP® Menopause formula contains the high-GUS (β-glucuronidase) activity strain Levilactobacillus brevis KAB®-052, which plays a crucial role in modulating estrogen levels in peri- and postmenopausal women. This breakthrough probiotic blend helps maintain serum estradiol and estrone levels over a 12-week period, offering a novel, natural solution for balancing hormones during menopause. The clinical evidence behind this formula underscores the potential of precision probiotics in influencing hormone regulation through the gut microbiome.
Focusing on Women’s Health Needs
At Kaneka Probiotics, we are dedicated to placing women’s health at the center of our innovation. We recognize the persistent gaps in research and solutions tailored specifically for women. As a leading probiotic manufacturer, we aim to bridge these gaps with our precision probiotic formulas, which address the unique health needs of women throughout their life stages, from adolescence to post-menopause. These needs include digestive wellness, immune support, skin health, cognition, and hormonal balance.
Precision Probiotics for Targeted Benefits
What sets Kaneka apart in the competitive world of probiotics is our focus on precision. We believe that not all probiotics are created equal. Rather than simply increasing CFU counts, we select strains based on their specific mechanisms of action and their ability to produce meaningful health benefits. This precision approach is rooted in microbiome science, where we target the right probiotic for the right purpose. For instance, the KABP® Menopause blend specifically targets the estrobolome—a collection of gut microbes that influence estrogen metabolism.
The estrobolome plays a critical role in estrogen homeostasis, influencing how much estrogen is recirculated in the body. In women experiencing menopause, the natural decline in estrogen levels can lead to various health challenges, including changes in mood, energy, and skin elasticity. Dysbiosis, or an imbalance in the gut microbiome, can disrupt the estrobolome and exacerbate these symptoms. KABP®Menopause aims to restore balance by supporting the gut’s ability to balance estrogen levels, providing a natural way to manage menopause-related hormone fluctuations.
Ongoing Research and Clinical Trials
Our commitment to women’s health is further reflected in our ongoing clinical trials and collaborations with top research institutions. Since 2015, Kaneka has been at the forefront of probiotic research, leading studies in vaginal health, urinary tract health, and hormonal support. Our current trials build on nearly a decade of research, focusing on menopause, urinary tract health, and vaginal colonization.
A Vision for the Future of Women’s Health
As a probiotic manufacturer, Kaneka’s vision is clear: to continue pioneering microbiome-based solutions that address real-world health concerns. Winning the NutraIngredients-USA Award for Microbiome Modulation is a testament to our relentless pursuit of science-backed innovation. We look forward to advancing women’s health with our precision probiotics, ensuring that women across the globe can live healthier, more balanced lives.